Related Articles
Predictive value of phosphorylated mammalian target of rapamycin for disease‑free survival in breast cancer patients receiving neoadjuvant chemotherapy
Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer
Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo
Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells
Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma